Ependymoma Market: Global Industry Analysis and Forecast 2016 - 2024

Ependymoma Market: Global Industry Analysis and Forecast 2016 - 2024

Persistence Market Research

Ependymoma Market: Global Industry
Analysis and Forecast 2016 - 2024

Persistence Market Research

1

Ependymoma Market: Global Industry Analysis and Forecast 2016 - 2024
Persistence Market Research Released New Market Report on “Ependymoma Market: Global
Industry Analysis and Forecast 2016 - 2024”.
Ependymoma are tissue-based tumors arising from the cells lining the ventricles and central
canal within the spinal cord. Symptoms of ependymal tumors are related to the area within the
brain and size of the tumor. Increased head size may be one of the first symptoms noted in
pediatric patients. Irritability, sleeplessness, and vomiting symptoms may develop with growth of
tumor. In older children and adults, nausea, vomiting, and headache, are the most common
symptoms noted. According to American Brain Tumor Association, ependymomas are relatively
rare tumors occurring in adults, accounting for 2-3% of primary brain tumors. However, there are
the sixth most common brain tumor occurring in pediatric patients. About 30% of pediatric
ependymoma are diagnosed in children younger than three years of age. Like many tumor
types, the exact cause of ependymoma is not known. Unknown causes and lucrative revenue
prospects have grabbed attention from big drug makers and thus the market is expected to
exhibit significant growth in market value over the forecast years.
The global ependymoma market could be segmented based on type of disease and
treatment.


Based on type of disease,



Myxopapillary Ependymomas



Subependymomas



Classic Ependymomas



Anaplastic Ependymomas



Based on treatment type,



Radiotherapy



Surgery



Chemotherapy



Steroids



Anticonvulsants



Segmentation based on regions

Based on disease type, myxopapillary ependymomas occur primarily at the base area of spine...